CTRI/2021/01/030636Not yet recruitingPhase 4
Assessment Of Hypoglycemic Effect Using Holistic Approach Of Ayurveda Protocol For The Management Of Prameha/Madhumeha With Special Reference To DM Type 2 Using Different Dosages Pattern: A Therapeutic Clinical Trial - AHHAPMPMDM
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients of either gender in the age group of 25-65years.
- •2. Patients with classical signs and symptoms of Prameh/Madhumeha viz Prabhuta
- •Mutrata, Avila Mutrata, Pipasadhikya, Alasya, Utsahahani, Kshudhadhikya,
- •Pindikodveshthana, Karapadatala Suptata, Daurbalya, Nidradhikya and
- •Purishabadhdhata.
- •3. Patients with random blood sugar level (RBS) >200 mg/dl up to 450
- •4. Fasting blood sugar (FBS) >110 mg/dl up to 300 mg/dl
- •5. Postprandial blood sugar (PPBS) >140 mg/dl up to 450 mg/dl
- •6. Glycosylated haemoglobin > 6.5%.
- •7. Newly /early diagnosed cases to be included as per following criteria:
- •i. Patients who are not taking any conventional medicine for more than two
- •months, whose sugar levels are raised and fall within the inclusive criteria
- •mentioned above and are willing to take Ayurvedic treatment.
- •ii. Patient accidently diagnosed in routine check-up or when appeared with other
- •complaints in the hospital.
- •iii. Early diagnosed diabetic patients (less than 2yr of diabetic history) and not
- •taking any pharmacological drugs since last two months
Exclusion Criteria
- •1. Patients having insulin dependent DM (type 1) and receiving insulin / OHA
- •2. Excessive blood glucose: FBS > 300 mg/dl and PPBS > 450 mg/dl
- •3. Emergency conditions in cases of DM.
- •4. Patients with acute/chronic liver disease with elevated liver enzymes.
- •5. Chronic complications like microvascular and macrovascular derangements.
- •6. Hyperthyroidism or hypothyroidism
- •7. Patients reporting to be hypersensitive to any of the proposed trial drugs.
- •8. Pregnant women/ lactating mothers
- •9. Participation in other clinical studies in past 12 weeks.
- •10. Takes psychotropic medications that raise blood glucose (e.g. atypical antipsychotics)
Investigators
Similar Trials
Not yet recruiting
Phase 4
Effect Of Haridra Churna (Haldi) in Reducing Blood Sugar in Madhumeha (Diabetes Mellitus)CTRI/2020/02/023430Department of Kayachikitsa Ch Brahm Prakash Ayurved Charak Sansthan
Completed
Not Applicable
Efficacy, effect of hypoglycemia, assessment of QOL to use FreeStyle Libre Flash Glucose Monitoring System in type 1 diabetisType1 diabetes using insulinJPRN-UMIN000029837Medical Corporation H.E.C Science Clinic30
Completed
Not Applicable
Efficacy, effect of hypoglycemia, assessment of QOL to use FreeStyle Libre Flash Glucose Monitoring System in type 2 diabetisJPRN-UMIN000029842Medical Corporation H.E.C Science Clinic30
Not yet recruiting
Phase 2
clinical evaluation of Panchtikta Churna in Madhumeha (type 2 Diabetes Mellitus)CTRI/2024/01/061587Ayurvedic and Unani Tibbia college
Completed
Not Applicable
The comparison of the hypoglycemic effect between insulin glargin U-300 and insulin glargiJPRN-UMIN000023360Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School,40
